Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Isoquercitrin is a quercetin-3-glucoside flavonol glycoside that demonstrates antiviral and vascular protective effects through inhibition of viral replication and stabilization of endothelial barrier function. Clinical trials show efficacy in reducing COVID-19 symptom duration and preventing dengue-related vascular leakage.
Origin & History
Isoquercitrin is a naturally occurring flavonoid glycoside consisting of quercetin linked to a glucose molecule, found in cotton, onions, apples, and mangosteen. It appears as a white to dark yellow powder with limited water solubility and can be extracted from natural sources or produced enzymatically from quercetin.
Research Narrative (Provisional)
Clinical evidence for isoquercitrin is limited but promising, with a phase 2 RCT (PMID: 34469660) showing reduced COVID-19 symptoms at 500 mg/day, and another RCT (PMID: 35622900) demonstrating vascular protection in dengue patients at 800 mg/day. A pharmacokinetic study (PMID: 32980913) confirmed safety at 50-200 mg single doses, though no large meta-analyses exist specifically for isoquercitrin.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Isoquercitrin (quercetin-3-O-β-D-glucopyranoside, C₂₁H₂₀O₁₂, MW 464.38) is a flavonol glycoside, not a macronutrient source. Key bioactive properties: 8 hydrogen-bond donors enabling potent radical scavenging (ORAC value ~5× higher than quercetin aglycone in aqueous systems). Water solubility is significantly improved over quercetin (~170× more soluble) due to the glucose moiety, yielding substantially higher oral bioavailability (Cmax approximately 3-5× that of quercetin in pharmacokinetic studies). Enzymatically modified isoquercitrin (EMIQ), produced via α-glucosylation, further enhances solubility and absorption (~17× greater bioavailability than quercetin). Typical supplemental doses range from 50-500 mg/day. No significant vitamin or mineral content; value is entirely as a polyphenolic bioactive. Undergoes deglycosylation by intestinal β-glucosidases (lactase-phlorizin hydrolase) in the small intestine, releasing quercetin aglycone for absorption, with additional colonic microbial metabolism producing ring-fission products (3,4-dihydroxyphenylacetic acid, etc.).
Reported Mechanism (Provisional)
Isoquercitrin inhibits viral replication by blocking 3CLpro and PLpro proteases essential for SARS-CoV-2 lifecycle. It stabilizes endothelial tight junctions through upregulation of VE-cadherin and claudin-5 proteins while reducing inflammatory cytokines IL-6 and TNF-α. The compound also scavenges reactive oxygen species via donation of electrons from hydroxyl groups on its flavonol backbone.
Clinical Narrative (Provisional)
A phase 2 randomized controlled trial (n=140) demonstrated that isoquercitrin reduced COVID-19 symptom duration with a hazard ratio of 1.36 (p=0.018) and improved oxygen saturation levels. In dengue fever patients, an RCT (n=79) showed significant reduction in vascular leakage measured by plasma extravasation scores (p<0.05). However, evidence remains limited to these two viral infection studies. Additional research is needed to establish broader therapeutic applications and optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.